DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Aspartame is an investigational drug.
There have been 5 clinical trials for Aspartame. The most recent clinical trial was a Phase 2 trial, which was initiated on March 8th 2019.
The most common disease conditions in clinical trials are Diabetes Mellitus, Obesity, Abdominal, and Kidney Diseases. The leading clinical trial sponsors are University of Toronto, Universal Integrated Corp., and Singapore General Hospital.
There are two US patents protecting this investigational drug and thirty-five international patents.
Recent Clinical Trials for Aspartame
|Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy||Universal Integrated Corp.||Phase 3|
|Effects of Fenofibrate Therapy in Diabetic Nephropathy||National Medical Research Council (NMRC), Singapore||Phase 3|
|Effects of Fenofibrate Therapy in Diabetic Nephropathy||Singapore General Hospital||Phase 3|
Top disease conditions for Aspartame
Top clinical trial sponsors for Aspartame
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Aspartame||Start Trial||Halogen-substituted heterocyclic compound||UBE INDUSTRIES, LTD. (Ube-Shi, JP)||Start Trial|
|Aspartame||Start Trial||Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus||Seattle Genetics, Inc. (Bothell, WA)||Start Trial|
|Aspartame||Start Trial||Granulation of a stevia sweetener||PureCircle Sdn Bhd (Kuala Lumpur, MY)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|